CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or photothe...

Published 2017

Seasonal influenza immunization of health care workers for the prevention of influenza in patients : a review of the clinical effectiveness

by Seal, Kelsey, Spry, Carolyn
Published 2017

Entyvio (Vedolizumab)

Published 2016

Immune checkpoint inhibitors for classical Hodgkin lymphoma in brentuximab vedotin-naïve patients : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Williams, D., Gray, Casey, Picheca, Lory
Published 2019

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

HPV testing for primary cervical cancer screening : recommendations report

Published 2019

Masks for prevention of influenza transmission in acute and long-term care settings : a review of clinical effectiveness, cost-effectiveness and guidelines

by Marchand, Dave K., Argáez, Charlene
Published 2020

Pharmacoeconomic report: Satralizumab (Enspryng) : (Hoffmann-La Roche Limited) : indication : neuromyelitis optica spectrum disorder

Published 2021

Masks for prevention of influenza transmission in acute and long-term care settings : a review of clinical effectiveness, cost-effectiveness and guidelines

by Marchand, Dave K., Argáez, Charlene
Published 2020

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...

Published 2020

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada Corp.) : indication : the treatment of neuromyelitis optica spectrum disorder (NMOS...

Published 2020

Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease

Published 2021